CF PHARMTECH (02652) spent 1.6415 million Hong Kong dollars on February 26 to repurchase 43,000 shares.

17:50 26/02/2026

Chang Feng Pharmaceutical (02652) announced that on February 26, 2026, the company spent 1.6415 million Hong Kong dollars to repurchase 43,000 shares at a repurchase price of 37.88-38.48 Hong Kong dollars per share.

CF PHARMTECH (02652) announced on February 26, 2026, the company spent 1.6415 million Hong Kong dollars to repurchase 43,000 shares of stock at a repurchase price of 37.88-38.48 Hong Kong dollars per share.

OSHIDORI (00622) issued 760 million shares in accordance with the share exchange agreement.

JNBY (03306) will distribute a mid-year dividend of HK$0.52 per share on April 15th.

BEONE MEDICINES (06160) expects strong growth in performance in 2025, with adjusted net profit of approximately 918 million US dollars, turning losses into profits year-on-year.

OSHIDORI (00622) issued 760 million shares in accordance with the share exchange agreement.

JNBY (03306) will distribute a mid-year dividend of HK$0.52 per share on April 15th.

BEONE MEDICINES (06160) expects strong growth in performance in 2025, with adjusted net profit of approximately 918 million US dollars, turning losses into profits year-on-year.